Efforts to establish a specialist Scottish biotechnology company, developing treatments for chronic inflammatory diseases and fibrosis, have taken off following a funding award.

heriot-watt's pioneering efforts to tackle inflammation take step forward after funding boost
© Heriot-Watt’s Global Research Innovation and Discovery facility is playing a key role. Picture: cont…

“Ground-breaking” research from Heriot-Watt University and the University of Texas Medical Branch in the field is set to be commercialised after the funding award to the Edinburgh organisation from Scottish Enterprise’s High Growth Spinout Programme.

They explained that inflammation is the body’s normal healing response to damaging stimuli, including infections, injuries, and toxins, but chronic and untreated inflammatory disease can have serious consequences.

It has been calculated that three in every five people die as a result of such a disease, with examples including respiratory, cardiac, vascular, Covid-19 and related viral infections, which are extremely difficult to treat due to the complex nature of inflammatory processes, resulting in continual demand for new medications.

READ MORE: Biotech Roslin Technologies gets £1 million injection to help turn animal cells into sausages

However, the new research has identified a way of targeting an enzyme called EPAC1, which is involved in the inflammation process and is responsible for many of the most serious yet common chronic diseases.

The team said it has already developed several potential new treatment options that show effectiveness in tackling inflammation at its source. Such medications, once they reach the market, are expected to offer advantages over existing options in both efficacy and safety.

Dr Stephen Yarwood from the Institute of Biological Chemistry, Biophysics and Bioengineering at Heriot-Watt, said: “By activating our newly identified enzyme, we can essentially ‘switch off’ inflammation. By doing so, we believe we can stop the harm chronic inflammation can do and hope to improve outcomes for patients when these treatments come to market.

“This funding will allow us to commercialise the breakthrough, bringing the research out of the lab to create a biotechnology business focused exclusively on developing treatments to target inflammatory diseases… we intend to build a biotechnology company of significant scale and ambition.”

Victoria Carmichael, director of strategic investments at Scottish Enterprise, said: “Our High Growth Spinout Programme was established specifically to help commercialise ground-breaking research conducted by Scotland’s universities.

“The development of EPAC1 has the potential to alleviate the suffering caused to millions of people around the world and highlights the important innovation-led approach the country’s academic institutions continue to apply to the management of chronic diseases.”

Expertise

The funding will be used for further development of the treatments and has allowed the team to recruit commercial expertise from industry veteran Chris Wardhaugh, who will act as chief executive-designate for the project. The team, which includes Dr Graeme Barker, is working with Heriot-Watt’s Global Research Innovation and Discovery (Grid) facility.

Mr Wardhaugh said: “This funding is the first step in a long road to bringing important new options to clinicians and patients. The whole team recognises the support of Scottish Enterprise in encouraging the commercialisation of new research and we are excited about the prospects of laying the foundations for another Scottish biotechnology success story.”

Paul Devlin, head of commercialisation at Heriot-Watt, commented: “This funding will help accelerate the impact of academic discovery on the daily lives of people affected by a wide range of life-changing and life-limiting diseases.

“With Heriot-Watt’s expertise in delivering commercial, strategic and innovation support, coupled with the financial backing of Scottish Enterprise, we look forward to growing this research into an exciting, profitable, world-class business.”

A message from the Editor:

Thank you for reading this article. We’re more reliant on your support than ever as the shift in consumer habits brought about by coronavirus impacts our advertisers.

If you haven’t already, please consider supporting our trusted, fact-checked journalism by taking out a digital subscription.

TECH NEWS RELATED

Very Large Telescope images planet around most massive star pair to date

This image shows the most massive planet-hosting star pair to date, b Centauri, and its giant planet b Centauri b. This is the first time astronomers have directly observed a planet orbiting a star pair this massive and hot. The star pair, which has a total mass of at ...

View more: Very Large Telescope images planet around most massive star pair to date

Instagram Introduces New Features for Underage Users

Including a Take a Break tool

View more: Instagram Introduces New Features for Underage Users

How to Connect Wireless Headphones to Xbox One

Microsoft's protocol makes it easy

View more: How to Connect Wireless Headphones to Xbox One

Google Aims to Disrupt Botnet Targeting Windows Machines

It's attacking the Glupteba network both directly, and through litigation

View more: Google Aims to Disrupt Botnet Targeting Windows Machines

JOLTs job openings increased to 11 million in October

Yahoo Finance Live hosts Julie Hyman and Brian Cheung review the latest numbers in the Job Openings and Labor Turnover survey.

View more: JOLTs job openings increased to 11 million in October

HCL acquires banking firm in Germany

AgenciesThe country’s third largest software services firm, HCL and Deutsche Apotheker- und Ärztebank eG (apoBank), the largest cooperative primary bank in Germany, have signed with Atruvia AG an agreement to acquire IT consulting company Gesellschaft für Banksysteme GmbH (gbs). The transaction is expected to close in Jan. 2022. Post-closing, HCL ...

View more: HCL acquires banking firm in Germany

Ola raises $139 million funding at $7.3 billion valuation

Agencies Ola cofounder Bhavish Aggarwal Bengaluru-based mobility startup Ola has raised $139 million as part of its Series J (G4) funding round, led by Edelweiss PE, regulatory filings showed.The company paid Rs 26 crore to acquire geospatial services provider GeoSpoc, the filings also showed.ET was the first to report on ...

View more: Ola raises $139 million funding at $7.3 billion valuation

Reuters home


View more: Reuters home

Comet Leonard is buzzing past Earth and you have one chance to see it

Will AI take our jobs? UK workers don’t think so

How to create an automation in the Home app

Was Your iPhone Repaired With Genuine Parts? New iOS Update Will Tell You

Google, Roku Reach a Deal on YouTube Apps

How to set an iPhone sleep timer using Apple Music

Metrics can drive your growth — as long as you’re looking at the right ones

Man charged after Christmas tree outside Fox News building set on fire, police say

Google Stadia is finally available on LG TVs almost one year later

Govt blocked 9,849 social media URLs in 2020

How to Disable Power Nap in macOS

How to Transfer Photos From Your iPad to Your PC

OTHER TECH NEWS

;